5.11.2021 | Mezinárodní spolupráce
Spanish nanoscience and nanotechnology research centre has developed an innovative, biocompatible, flexible and modifiable catechol-based membrane for tissue regenerative applications. It shows adhesive properties in water environments, and its chemical properties are tuneable by functionalization with different (bio)molecules. Membrane thickness...
1.10.2021 | Mezinárodní spolupráce
A Danish biotechnology SME is developing a novel software for recombinant antibody-developers, giving them an easy-to-use tool to predict which antibodies are most likely to succeed during production. In the collaboration proposed, the partner will have free access to the solution during the closed beta in return for feedback on the use and...
10.9.2021 | Mezinárodní spolupráce
Bio-crystallography team with experience in supporting drug discovery projects organized a dedicated commercial laboratory in Poland’s leading biomedical research institute. X-ray crystallography is the primary method for determining the 3D structure of the protein or protein-ligand complexes. Biotech and pharma companies are sought for agreements...
20.8.2021 | Mezinárodní spolupráce
A Spanish university has developed a technology using bacteria which are capable of degradation and removal of Bisphenol A (BPA) a chemical that is present in many commercial products, including food containers and hygiene products.The university is looking for partners in order to licence the patented technology.
23.7.2021 | Mezinárodní spolupráce
A Spanish biotech company dedicated to developing first-in-class novel Therapeutic Molecular Clusters (TMCs) has a pipeline of molecules with potent anticancer activity by several mechanisms of action and molecules active against bacterial and fungal pathogens protected by patents. TMCs freely diffuse across the blood brain barrier and into...
2.7.2021 | Mezinárodní spolupráce
A Spanish biotechnology company is offering its extensive experience in fermentation and biomass scale-up with the aim of industrializing processes that involve the use of microorganisms. They are looking for clients interested in applying their solutions and partners for a possible cooperation through technical cooperation agreements or...
11.6.2021 | Mezinárodní spolupráce
A research group based in Italy has developed a new class of small molecules acting as SERPINA3 inhibitors, which are able to reduce prion protein (PrPSc) accumulation in prion-infected cell lines, thereby representing a new therapeutic treatment against prion and prion-like diseases. They are looking for licence agreements and joint venture...
7.5.2021 | Mezinárodní spolupráce
An Austrian SME is developing a novel hemoglobin complex for use in various in-vitro & in-vivo application areas. This complex is characterized by a high oxygen carrying capacity, purity, safety and functionality. The developers are looking for partners who need specific oxygen carriers or want to adopt the technology in their manufacturing...
23.4.2021 | Mezinárodní spolupráce
A Singapore institute of higher learning has developed a world-first clinically effective and pain-free treatment of pathological scars using topical small interfering RNA (siRNA) microneedles. This patented technology comprises of a dissolvable microneedle containing activated siRNA for scar treatment. The team is currently working towards...
2.4.2021 | Mezinárodní spolupráce
The French company is a European leader in bio-processes, industrial biotechnology and synthetic biology. It enables medium and large players in the processing industries (chemicals, pharma, food, cosmetics...) to source and produce their ingredients and chemicals in a cost effective and sustainable way. It helps them to expand their pipeline and...
Gate2Biotech - Biotechnologický portál - Vše o biotechnologiích na jednom místě.
ISSN 1802-2685
Tvorba webových stránek: CREOS CZ
© 2006 - 2022 Jihočeská agentura pro podporu inovačního podnikání o.p.s.
Zajímavé články s biotechnologickým obsahem:
Práce na vedlejší pracovní poměr
Věda - Informace z vědy, výzkumu českých biotechnologií
Genetici úspěšně editovali klíště s editorem CRISPR
Anti GMO témata celosvětově ztrácejí na popularitě